Differences in baseline characteristics of newly diagnosed IPF patents in the EMPIRE countries

V. Müller (Budapest, Hungary), M. Šterclová (Prague, Czech Republic), N. Mogulkoc (Izmir, Turkey), J. Kus (Warsaw, Poland), M. Hájková (Bratislava, Slovakia), D. Jovanovic (Belgrade, Republic of Serbia), J. Tekavec-Trkanjec (Zagreb, Croatia), M. Svoboda (Brno, Czech Republic), M. Janotová (Brno, Czech Republic), M. Vašáková (Prague, Czech Republic)

Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Session: The world of idiopathic pulmonary fibrosis (IPF): global registries
Session type: Poster Discussion
Number: 2204
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Müller (Budapest, Hungary), M. Šterclová (Prague, Czech Republic), N. Mogulkoc (Izmir, Turkey), J. Kus (Warsaw, Poland), M. Hájková (Bratislava, Slovakia), D. Jovanovic (Belgrade, Republic of Serbia), J. Tekavec-Trkanjec (Zagreb, Croatia), M. Svoboda (Brno, Czech Republic), M. Janotová (Brno, Czech Republic), M. Vašáková (Prague, Czech Republic). Differences in baseline characteristics of newly diagnosed IPF patents in the EMPIRE countries. 2204

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences between newly and previously diagnosed COPD patients in a spirometry program
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009


Differences in patient characteristics and associations with comorbid load in Dutch and Australian COPD patients
Source: International Congress 2016 – Latest insights into chronic care
Year: 2016

Characteristics and treatment patterns of newly diagnosed COPD patients in Canada
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019

Differences and similarities in bronchiectasis in developing and developed countries
Source: International Congress 2017 – Non-CF bronchiectasis in children
Year: 2017


Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Russian IPF Registry: time of inclusion impacts patients’ status
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020

Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Comorbidities in patients with COPD: Associations with clinically relevant parameters
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010

Gender differences in health status in patients with COPD: baseline characteristics of a multi-centre intervention and characterisation study on Seretide (COSMIC)
Source: Eur Respir J 2002; 20: Suppl. 38, 262s
Year: 2002

Gender differences in COPD treatment and morbidity in patients from the confronting COPD international survey
Source: Eur Respir J 2003; 22: Suppl. 45, 216s
Year: 2003

A comparison of the management of COPD exacerbations in six European hospitals: demographics and baseline data
Source: Annual Congress 2008 - Management of COPD
Year: 2008



Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014


The prevalence and clinical characteristics of asthma–COPD overlap syndrome (ACOS) in patients with COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

Socio-demographic and clinical characteristics of patients with tuberculosis and diabetes in European countries. A TB-net study
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016

Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

Differences between men and women COPD admissions: Evidence from the European COPD audit
Source: Annual Congress 2012 - Acute exacerbation in COPD
Year: 2012


The COPD patient’s journey - newly diagnosed COPD patients in the UK Mediplus database
Source: Eur Respir J 2004; 24: Suppl. 48, 143s
Year: 2004

Impact of age in the clinical expression of COPD in Greek patients
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009